Protagenic Therapeutics gets FDA pre-IND feedback for PT00114
Protagenic Therapeutics says the FDA provided pre-IND feedback supporting a new IND for PT00114 in generalized anxiety disorder.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.